Viewing Study NCT05574335

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:04 PM
Ignite Modification Date: 2026-01-01 @ 10:20 PM
Study NCT ID: NCT05574335
Status: TERMINATED
Last Update Posted: 2025-12-19
First Post: 2022-09-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Siplizumab in T1DM
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 1 Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None diabetic View
None Type 1 diabetes View
None T1DM View
None siplizumab View